Halozyme Therapeutics, Inc. - Common Stock (NQ:HALO)

68.67 +0.31 (+0.45%)

Streaming Delayed Price Updated: 11:26 AM EST, Dec 24, 2025 Add to My Watchlist

Price and Volume

Volume	124,264
Open	68.72
Bid (Size)	68.66 (300)
Ask (Size)	68.71 (400)
Prev. Close	68.36
Today's Range	68.31 - 69.01
52wk Range	46.26 - 79.50
Shares Outstanding	142,334,900
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Halozyme Therapeutics (NASDAQ:HALO): A Prime GARP Stock with Strong Growth and Value ↗

December 13, 2025

Halozyme (HALO) exemplifies GARP investing, offering strong growth at a reasonable price with high profitability and a low P/E ratio.

Via Chartmill

The Healthcare Sector Is Surging. Here's 1 Stock Every Investor Should Have on Their Radar. ↗

December 06, 2025

Investing in Halozyme Therapeutics is a compelling way to gain exposure to the broader healthcare and biotechnology industries.

Via The Motley Fool

Performance

YTD	+43.0%	+43.0%
1 Month	-7.2%	-7.2%
3 Month	-11.5%	-11.5%
6 Month	+27.4%	+27.4%
1 Year	+45.6%	+45.6%

More News

Halozyme Therapeutics Inc (NASDAQ:HALO) Presents a Compelling Case for Value Investors ↗

November 24, 2025

Via Chartmill

HALOZYME THERAPEUTICS INC (NASDAQ:HALO) Shows Strong Growth Momentum and Bullish Technical Setup ↗

November 21, 2025

Via Chartmill

Why I Keep Buying These 10 Incredible Growth Stocks ↗

November 17, 2025

Via The Motley Fool

Earnings Scheduled For November 3, 2025 ↗

November 03, 2025

Via Benzinga

Halozyme Therapeutics Inc (NASDAQ:HALO) Embodies Affordable Growth with Strong Metrics ↗

November 17, 2025

Via Chartmill

Halozyme Therapeutics Inc (NASDAQ:HALO) Shows Strong Technical and Fundamental Momentum ↗

November 14, 2025

Via Chartmill

Halozyme Stock Surging On Recent Earnings Beat; Record High Ahead? ↗

November 12, 2025

Via Investor's Business Daily

Halozyme Therapeutics Inc (NASDAQ:HALO) Shows Strong Growth and Technical Breakout Potential ↗

November 11, 2025

Via Chartmill

Ligand Pharmaceuticals Soars to New Heights: A Deep Dive into its 52-Week High

November 06, 2025

Via MarketMinute

Renaissance Group Opens New $35M Position in Halozyme Therapeutics (NASDAQ: HALO): Why This Biotech Stock Is Worth a Look ↗

November 05, 2025

Via The Motley Fool

Halozyme (HALO) Q3 2025 Earnings Call Transcript ↗

November 03, 2025

Via The Motley Fool

Insights into Halozyme Therapeutics's Upcoming Earnings ↗

October 31, 2025

Via Benzinga

Halozyme Therapeutics Inc (NASDAQ:HALO) Fits a Proven Growth Investing Method ↗

October 30, 2025

Via Chartmill

Koa Wealth Liquidates All 68K IIPR Shares Valued at $3.8 Million ↗

October 29, 2025

Via The Motley Fool

HALOZYME THERAPEUTICS INC (NASDAQ:HALO) Combines Strong Growth Momentum with Technical Breakout Setup ↗

October 27, 2025

Via Chartmill

Halozyme Therapeutics Inc (NASDAQ:HALO) Presents a Compelling Value Investment Case ↗

October 25, 2025

Via Chartmill

Halozyme Therapeutics Inc (NASDAQ:HALO) Offers an Affordable Growth Profile ↗

October 21, 2025

Via Chartmill

Halozyme Therapeutics Inc (NASDAQ:HALO): A Growth Stock Poised for a Breakout ↗

October 18, 2025

Via Chartmill

The Analyst Verdict: Halozyme Therapeutics In The Eyes Of 10 Experts ↗

October 15, 2025

Via Benzinga

Halozyme Therapeutics Inc (NASDAQ:HALO) Demonstrates Strong Growth and Profitability ↗

October 09, 2025

Via Chartmill

Halozyme Therapeutics Inc (NASDAQ:HALO): A Prime Candidate for Affordable Growth ↗

September 26, 2025

Via Chartmill

Forecasting The Future: 7 Analyst Projections For Halozyme Therapeutics ↗

September 22, 2025

Via Benzinga

Halozyme Therapeutics Inc (NASDAQ:HALO) Presents a High-Growth Momentum and Technical Breakout Opportunity ↗

September 20, 2025

Via Chartmill

Frequently Asked Questions

Is Halozyme Therapeutics, Inc. - Common Stock publicly traded?

Yes, Halozyme Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Halozyme Therapeutics, Inc. - Common Stock trade on?

Halozyme Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Halozyme Therapeutics, Inc. - Common Stock?

The ticker symbol for Halozyme Therapeutics, Inc. - Common Stock is HALO on the Nasdaq Stock Market

What is the current price of Halozyme Therapeutics, Inc. - Common Stock?

The current price of Halozyme Therapeutics, Inc. - Common Stock is 68.67

When was Halozyme Therapeutics, Inc. - Common Stock last traded?

The last trade of Halozyme Therapeutics, Inc. - Common Stock was at 12/24/25 11:26 AM ET

What is the market capitalization of Halozyme Therapeutics, Inc. - Common Stock?

The market capitalization of Halozyme Therapeutics, Inc. - Common Stock is 9.77B

How many shares of Halozyme Therapeutics, Inc. - Common Stock are outstanding?

Halozyme Therapeutics, Inc. - Common Stock has 10B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.